What is Dexcare?
Dexcare, incubated at Providence, one of the nation's largest health systems, operates as a data-driven intelligence company dedicated to enhancing healthcare accessibility. Its core offering is a specialized software platform exclusively provided to health systems. This platform is designed to orchestrate digital demand with health system capacity across all care lines. By offering a highly discoverable, fully-digitized, and unified consumer experience, Dexcare attracts high-value, commercially-insured individuals while amplifying the existing investments health systems have in their EMR, caregiver networks, and brand. The platform's unique strength lies in its intelligent navigation and load balancing capabilities, efficiently directing patients across various providers, settings, modalities, and service lines. Dexcare's data-driven engine dynamically allocates, flexes, and optimizes resources to align with both consumer demand and the business objectives of health systems. Prominent health systems across the U.S., including Kaiser Permanente, Houston Methodist, and Mass General Brigham, utilize Dexcare to power their digital operations.
How much funding has Dexcare raised?
Dexcare has raised a total of $75M across 1 funding round:
Series C
$75M
Series C (2023): $75M with participation from Transformation Capital, Kaiser Permanente, and ICONIQ Growth
Key Investors in Dexcare
Transformation Capital
Transformation Capital is a growth equity fund focused on innovative healthcare IT and services companies, providing strategic investment to fuel their expansion.
Kaiser Permanente
Kaiser Permanente, a leading not-for-profit healthcare organization, invests in solutions that enhance integrated medical services and patient-centered care delivery.
ICONIQ Growth
ICONIQ Growth partners with visionary leaders and entrepreneurs, providing capital and ecosystem support to companies driving global impact and innovation in their industries.
What's next for Dexcare?
With its recent major strategic investment, Dexcare is poised for accelerated growth and further development of its intelligent healthcare navigation platform. The substantial capital infusion is expected to fuel expansion into new markets, enhance its data analytics capabilities, and deepen its integration with existing health system infrastructure. This strategic financing underscores the market's confidence in Dexcare's model for optimizing patient flow and revenue generation within the complex healthcare landscape. Future initiatives will likely focus on expanding its client base among leading health systems and further refining its algorithms to improve patient acquisition, downstream revenue capture, cost savings, and patient satisfaction scores, solidifying its position as a critical digital engine for healthcare providers.
See full Dexcare company page
